DSP Healthcare Fund Direct Growth
NAV ₹52.597 on 13 November 2026
AMFI name: DSP Healthcare Fund - Direct Plan - Growth · Scheme code 145454 · ISIN INF740KA1LG1
Returns
To 13 November 2026. Up to 1 year: total change. 3 and 5 years: compound return a year.
| Period | This fund | NIFTY HEALTHCARE INDEX TRI | Category median |
|---|---|---|---|
| 1M | +7.14% | +8.67% | +8.37% |
| 6M | +17.33% | +12.84% | +10.20% |
| 1Y | +20.18% | +38.92% | +5.55% |
| 3Y | +21.74% | +28.05% | +16.88% |
| 5Y | +17.17% | - | +15.07% |
Benchmark: NIFTY HEALTHCARE INDEX TRI (total return index), measured over the same dates. The scheme document names BSE Healthcare TRI, which we do not hold, so this is the closest NSE index.
Category median: the middle return among Direct plans (Growth option) in AMFI's “Equity Schemes - Sectoral Fund” category, up to 20 funds with clean data. Ranks are under “Rank among peers”.
Risk
From daily NAVs. Alpha, beta and capture are measured against NIFTY HEALTHCARE INDEX TRI.
- Volatility
- 12.99%
- Annualised, 3 years
- Max drawdown
- -16.09%
- Worst fall from a peak, 3 years
- Sharpe ratio
- 1.21
- Return above the risk-free rate per unit of volatility, 3 years
- Sortino ratio
- 1.65
- Like Sharpe, counting only falls, 3 years
- Alpha
- +5.72%
- Return a year beyond what beta explains, 3 years
- Beta
- 0.44
- 1.00 moves in step with the benchmark, 3 years
- Upside capture
- 31%
- Share of the benchmark's rises captured, 3 years
- Downside capture
- 84%
- Share of the benchmark's falls taken (lower is better), 3 years
Every 3-year holding period
Compound return a year for each 3-year window in the NAV history we hold. Less sensitive to the end date than a single 3-year figure.
Rank among peers
Direct plans, Growth option, in AMFI's “Equity Schemes - Sectoral Fund” category. Each rank counts only the peers that have that figure.
| Rank | Scheme Name | 3Y Return | 1Y Return | Sharpe | Direct TER | AUM |
|---|---|---|---|---|---|---|
| #1 | Nippon India Mutual Fund | +46.52% | +60.64% | 1.07 | 1.06% | ₹1,100 Cr |
| #2 | HDFC Mutual Fund | +33.64% | +20.34% | 1.07 | 0.89% | ₹11,128 Cr |
| #3 | HDFC Mutual Fund | +31.28% | +31.60% | 1.76 | 1.03% | ₹3,128 Cr |
| #4 | SBI Mutual Fund | +25.42% | +26.07% | 1.47 | 0.76% | ₹5,565 Cr |
| #5 | HDFC Mutual Fund | +24.77% | +10.10% | 1.09 | 1.10% | ₹1,997 Cr |
| #6 | Mirae Asset Mutual Fund | +24.42% | +27.89% | 1.28 | - | ₹3,458 Cr |
| #7 | UTI Mutual Fund | +23.89% | +22.00% | 1.31 | 1.35% | ₹1,399 Cr |
| #8 | ICICI Prudential Mutual Fund | +22.73% | +10.29% | 0.95 | 2.08% | ₹3,926 Cr |
| #13 | DSP Healthcare FundCurrent Fund DSP Mutual Fund | +21.74% | +20.18% | 1.21 | 0.76% | ₹3,721 Cr |
Costs and fund facts
- Expense ratio (stated maximum)
- Direct 0.76% · Regular 2.06%
- Exit load
- 0.50% - Holding period from the date of allotment <= 1 month, Nil - Holding period from the date of allotment > 1 month (as a % of Applicable NAV)
- Fund size (all plans)
- ₹3,721 CrAverage, quarter to September 2026
- Benchmark
- BSE Healthcare TRICompared here with NIFTY HEALTHCARE INDEX TRI
- Allotment date
- 30 November 2018Scheme document
- Type
- An open ended equity scheme investing in healthcare and pharmaceutical sector
- AMFI scheme code
- 145454
Fund manager
- Chirag Daglisince 01-Dec-2020
How each manager has done since taking over: fund manager scorecard.
Investment objective
The primary investment objective of the scheme is to seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies/entities. There is no assurance that the investment objective of the Scheme will be achieved.
From the scheme summary document filed with AMFI.
SIP calculator
A monthly SIP replayed on this fund's actual daily NAVs: what it would be worth today.
About this fund
DSP Healthcare Fund Direct Growth is a mutual fund scheme from DSP Mutual Fund, listed by AMFI under “Equity Schemes - Sectoral Fund”. This page covers the Direct plan with the Growth option. Its NAV was ₹52.597 on 13 November 2026. It returned 20.18% over 1 year, 21.74% a year over 3 years and 17.17% a year over 5 years, measured from NAVs (3- and 5-year figures are annualised). Its benchmark, NIFTY HEALTHCARE INDEX TRI, returned 28.05% a year over 3 years. Its 3-year return ranks #13 of 142 Direct Growth plans in the same AMFI category. Q-Score: 90 out of 100, rated only against funds in the same category. The fund house rates its risk as “Very High” on the SEBI riskometer. Its average assets under management were ₹3,721 Cr across all plans for the quarter ending September 2026, as reported to AMFI. Its scheme summary document states a maximum expense ratio (TER) of 0.76% a year for the Direct plan. Managed by Chirag Dagli. Its scheme summary document gives the allotment date as 30 November 2018.
Figures are calculated from AMFI NAVs and index data, not taken from fund factsheets. Methodology. Past performance is not a guide to future returns.